Mayo Clinic
Jacksonville
Neill Graff-Radford, MD
Site PI
The research of Neill R. Graff-Radford, M.D., involves finding genes that help people age without becoming demented. He is also studying normal pressure hydrocephalus to find those patients with good outcomes from treatment with shunt surgery; working to find a blood test that could determine if a person is at risk of Alzheimer's disease and be used as a diagnostic test for Alzheimer's disease; examining differences in dementia between African-Americans and Caucasians; and collaborating to find genes related to Alzheimer's disease and frontotemporal dementia.
Gregg Day, MD
Site Co-PI
Dr. Gregory Day is an Associate Professor of Neurology, Director of the Division of Behavioral Neurology, and Vice Chair of Research for the Department of Neurology at Mayo Clinic in Florida. His research is supported by the National Institute of Aging and focuses on improving the clinical diagnosis, characterization, and treatment of individuals with common and uncommon causes of dementia, including patients with neurodegenerative and autoimmune causes of rapid progressive dementia. Dr. Day is a project PI of the ExTINGUISH Trial—the first multisite randomized controlled trial for patients with anti-NMDAR encephalitis. ExTINGUISH is supported by the National Institutes of Neurological Disease and Stroke via the NeuroNEXT Network.
Anton Thomas
Site Liaison
